Published
1 hour ago
on
July 31, 2025
| 19 views
-->
By
Julia Wendling
Graphics & Design
- Lebon Siu
The following content is sponsored by Inigo Insurance
The $5.6T Pharmaceutical Industry in One Giant Chart
Pharma giants don’t just make medicine—they shape the future of healthcare. From determining which treatments reach patients to setting costs and driving innovation, their influence extends across both health outcomes and financial markets.
This visualization, created in partnership with Inigo Insurance, ranks the largest pharmaceutical companies in the world by market capitalization, using data from companiesmarketcap.com.
The Top Dog: Eli Lilly
Eli Lilly dominates the industry with a staggering market cap of $686 billion, nearly double that of Johnson & Johnson, the second largest company, at $359 billion. Eli Lilly’s value has skyrocketed since 2020, climbing from roughly $130 billion, largely fueled by the runaway success of its weight-loss drugs, Mounjaro and Zepbound.
| Rank | Company Name | Market Cap ($ billions) |
|---|---|---|
| 1 | Eli Lilly | 686 |
| 2 | Johnson & Johnson | 359 |
| 3 | Novo Nordisk | 334 |
| 4 | AbbVie | 327 |
| 5 | Roche | 255 |
| 6 | Novartis | 229 |
| 7 | AstraZeneca | 217 |
| 8 | Merck | 200 |
| 9 | Amgen | 156 |
| 10 | Pfizer | 136 |
| 11 | Gilead Sciences | 135 |
| 12 | Sanofi | 116 |
| 13 | Vertex Pharmaceuticals | 113 |
| 14 | Bristol-Myers Squibb | 96 |
| 15 | CVS Health | 85 |
| 16 | Chugai Pharmaceutical | 81 |
| 17 | GlaxoSmithKline | 78 |
| 18 | CSL | 75 |
| 19 | Zoetis | 70 |
| 20 | Merck KGaA | 55 |
Indeed, in the first quarter of 2025, worldwide revenue increased 45% to $12.73 billion, driven by volume growth from Mounjaro and Zepbound.
Other Pharma Heavy Hitters
There are three other companies with market caps above $300 billion: Johnson & Johnson with $359 billion, Novo Nordisk with $334 billion, and AbbVie with $327 billion.
Novo Nordisk also benefited from the weight-loss drug boom, with products like Ozempic and Wegovy driving growth. However, after peaking near $640 billion in mid-2024, its valuation has since cooled.
Roche, valued at $255 billion, joins other major players alongside Novartis at $229 billion, AstraZeneca at $217 billion—one of the first companies to release a COVID-19 vaccine—and Merck at $200 billion.
Pfizer ranks 10th with a market cap of $136 billion and is best known for blockbuster drugs like Viagra. Merck KGaA holds the 20th spot with a valuation of $55 billion, carrying the distinction of being the world’s oldest pharmaceutical company, founded in Germany in 1668.
The Future of Pharma
Doctors prescribe and patients decide, but pharma giants ultimately control which drugs they develop, who gets access, and what price they charge. Understanding who dominates this $5.6 trillion industry provides critical insight into the future of healthcare.
Explore Inigo’s Hub.
More from Inigo Insurance
-
Crime3 weeks ago
6 Fraud Trends Reshaping Risk in 2025
The fraud and financial crime landscapes are evolving rapidly. What are the key threats shaping risk in 2025?
-
Cryptocurrency3 weeks ago
Ranked: The 10 Biggest Digital Heists
Some of the largest digital heists didn’t rely on brute-force hacking, they exploited the weakest link in security: human trust.
-
Crime3 weeks ago
The Most Costly Financial Crimes in 2024
As cybersecurity threats escalate, which financial crimes are causing the most harm? The FBI has the data.
-
Crime4 weeks ago
Mapped: U.S. Financial Crime Activity by State
Suspicious activity has been rising in the U.S., but is it spread evenly throughout all 50 states? Certainly not.
Subscribe
Please enable JavaScript in your browser to complete this form.Join the 375,000+ subscribers who receive our daily email *Sign Up